Dr. Alex D. Federman, MD

Dr. Federman practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Federman's NPI, 1730110743, was assigned on July 6, 2006. Dr. Federman graduated from State University of NY Upstate Medical University in 1996. Dr. Federman holds New York license 209905.

Dr. Federman's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Federman also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Federman's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Federman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Federman practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Federman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Federman is licensed in New York.

CMS data shows 64 Medicare services from Dr. Federman across 2 procedure codes in 2024, all of them office visits, for 29 Medicare patients. Medicare paid $5,716 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 29 Medicare patients who saw Dr. Federman in 2024. The largest group is 65 to 74, with 15 patients. 66% of them have high cholesterol, and 59% have high blood pressure. 38% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Federman's median patient age at 68, with 51% women.

In 2024, Dr. Federman wrote 1,392 Medicare Part D claims for 114 patients. 83% of them were for generic drugs. CMS names the drug for 934 of them, across 34 drugs with 11 or more claims each, at $126,385 in total drug cost. In 2023, CMS named 919 claims across 35 drugs.

Dr. Federman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Federman from 2 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 82% of the total. Novartis Pharmaceuticals Corporation paid the most, $6,176.

Dr. Federman graduated from State University of NY Upstate Medical University in 1996.